Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obeticholic Acid216 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A49230 | 35814516 | J Clin Exp Hepatol | Pharmacotherapeutic Impact on Nonalcoholic Steatohepatitis Histology: A Systematic Review and Network Meta-analysis. | 2022 | Details |
| A49608 | 35693370 | Cureus | Comparing the Efficacy and Safety of Obeticholic Acid and Semaglutide in Patients With Non-Alcoholic Fatty Liver Disease: A Systematic Review. | 2022 | Details |
| A49754 | 35646540 | Acta Pharm Sin B | Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases. | 2021 | Details |
| A49799 | 35634402 | Front Nutr | Liver Protein Expression in NASH Mice on a High-Fat Diet: Response to Multi-Mineral Intervention. | 2022 | Details |
| A49846 | 35623174 | Biomed Pharmacother | Corydalis saxicola Bunting Total Alkaloids ameliorate diet-induced non-alcoholic steatohepatitis by regulating hepatic PI3K/Akt and TLR4/NF-κB pathways in mice. | 2022 | Details |
| A49864 | 35614939 | Front Pharmacol | Obeticholic Acid Induces Hepatoxicity Via FXR in the NAFLD Mice. | 2022 | Details |
| A49865 | 35614896 | Visc Med | Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A Narrative Review. | 2021 | Details |
| A49933 | 35589613 | Diabetes Obes Metab | Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications. | 2022 | Details |
| A50078 | 35535064 | J Clin Exp Hepatol | Characterization and Pharmacological Validation of a Preclinical Model of NASH in Göttingen Minipigs. | 2021 | Details |
| A50136 | 35507280 | Curr Atheroscler Rep | Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease. | 2022 | Details |
| A50275 | 35447541 | Biomed Pharmacother | Obeticholic acid inhibits hepatic fatty acid uptake independent of FXR in mouse. | 2022 | Details |
| A50299 | 35439472 | Chem Biol Interact | Obeticholic acid orchestrates the crosstalk between ileal autophagy and tight junctions in non-alcoholic steatohepatitis: Role of TLR4/TGF-β1 axis. | 2022 | Details |
| A50747 | 35279807 | Indian J Gastroenterol | Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis. | 2022 | Details |
| A51114 | 35686937 | Hepatology | IL-31 Levels Correlate with Pruritus in Patients with Cholestatic and Metabolic Liver Diseases and is FXR Responsive in NASH. | 2022 | Details |
| A51443 | 35348137 | Lab Chip | Integration of a microfluidic multicellular coculture array with machine learning analysis to predict adverse cutaneous drug reactions. | 2022 | Details |
| A51672 | 35059746 | J Mol Med (Berl) | Recapitulating lipid accumulation and related metabolic dysregulation in human liver-derived organoids. | 2022 | Details |